# A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

> **NCT02651753** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 48 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Lipitor + Lipidil supra
- **DRUG:** CKD-337

## Key facts

- **NCT ID:** NCT02651753
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-03
- **Final completion:** 2016-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651753, "A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02651753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*